Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 31, 2025
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
GlobeNewswire
·
March 31, 2025
REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that the …
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update
GlobeNewswire
·
March 31, 2025
Enables women to access a solution that they want and need Creates an opportunity to accelerate revenue generation from this proprietary formulation Daré expects to start recording revenue and cash flow in the 4th quarter of this year Conference call today …
Ascilion to present at the 8th International Conference on Microneedles in Brisbane
EIN Presswire
·
March 31, 2025
Ascilion's products for dermal interstitial fluid sampling will be the focus of six different presentations at the Microneedles 2025 Conference. STOCKHOLM, SWEDEN, March 31, 2025 /EINPresswire.com/ -- Ascilion AB ("Ascilion") the leader in dermal …
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
GlobeNewswire
·
March 31, 2025
WOODCLIFF LAKE, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has entered into a royalty purchase agreement with an entity that was provided capital by funds managed …
Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion
GlobeNewswire
·
March 31, 2025
Niagara Falls, NY, March 31, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC) (the “Company”), a leading molecular imaging medical device company specializing in Positron Emission Tomography (PET) and PET-CT imaging systems and clinical support …
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 31, 2025
SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual …
Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 31, 2025
-Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain (“CINP”) Phase 2b Trial - - Halneuron® CINP P2b study interim data readout is expected in Q4 2025 - - Conversion of existing $19.5M in debt to …
Saskatchewan’s 6% PST on Vaping Undermines Harm Reduction, Fuels Illicit Market
GlobeNewswire
·
March 31, 2025
Ottawa, ON, March 31, 2025 (GLOBE NEWSWIRE) -- Last week, the Saskatchewan government announced it will remove the 6% provincial sales tax (PST) exemption on vaping products, effective June 1, 2025. As the national voice for the vaping industry, the …
New Book 'Late To Your Own Funeral' Aims to Transform the Conversation around Death for Younger Generations
EIN Presswire
·
March 31, 2025
Guide Offers Readers Practical and Relevant Estate Planning Strategies ATLANTA, GA, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- Rachel Donnelly, founder and CEO of AfterLight, has released "Late To Your Own Funeral," a comprehensive guide …
Theriva™ Biologics anuncia resultados positivos de la segunda reunión del Comité independiente para la monitorización de los datos de VIRAGE, el ensayo clínico de Fase 2b de VCN-01 de la empresa en combinación con quimioterapia para el adenocarcinoma p…
GlobeNewswire
·
March 31, 2025
ROCKVILLE, Maryland, March 31, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), una empresa diversificada en fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas en áreas de gran necesidad …
BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today
GlobeNewswire
·
March 31, 2025
SUNNYVALE, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today clarifies that two-year CardiAMP-HF results …
New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable
GlobeNewswire
·
March 31, 2025
More than 92% of schizophrenia patients taking TEV-'749 in the SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication1 New data from UZEDY® (risperidone) evaluated predictors of response in …
CORRECTION - Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024
GlobeNewswire
·
March 31, 2025
PLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Please note that, in a release issued under the same headline earlier today by Vaso Corporation (OTCQX: VASO), some figures in the written description of the financial results for the three months and the …
Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-1 Targeted ADC, for Hematologic and Solid Malignancies
GlobeNewswire
·
March 31, 2025
BOSTON, Mass, March 31, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today announced that the U.S. Food and Drug Administration (“ …
Sandoz strengthens its balance sheet by issuing new bonds to repay spin-off term loans, and signs new USD 2 billion revolving credit facility
GlobeNewswire
·
March 31, 2025
MEDIA RELEASE NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN New USD 2.0 billion multi-currency revolving credit facility (RCF) in place to further strengthen Sandoz balance sheet and liquidity New facility replaces initial …
PracticeLink Announces New “First Practice Fund” Scholarship to Support Physicians
GlobeNewswire
·
March 31, 2025
ST. LOUIS and HINTON, West Virginia, March 31, 2025 (GLOBE NEWSWIRE) -- PracticeLink, the nation’s most trusted physician recruitment resource and home of the most widely used online physician job board, announces its new “First Practice Fund” scholarship …
Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast
GlobeNewswire
·
March 31, 2025
PITTSBURGH, March 31, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today announced that Co- …
Global Cannabis Cosmetics Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034
EIN Presswire
·
March 31, 2025
The Business Research Company's Cannabis Cosmetics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ -- The cannabis cosmetics market has witnessed …
In-Depth Analysis of the Cannabis Infused Products Market: Key Drivers, Trends, Opportunities, and Forecast 2025-2034
EIN Presswire
·
March 31, 2025
The Business Research Company's Cannabis-Infused Products Global Market Report 2025 – Market Size, Trends, And Global Forecast 2023-2032 LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ -- The Global Forecast: What Does The …
Sierra Tucson Partners with Blue Cross® Blue Shield® of Arizona
GlobeNewswire
·
March 31, 2025
TUCSON, Ariz., March 31, 2025 (GLOBE NEWSWIRE) -- Sierra Tucson is pleased to announce that it has partnered with Blue Cross® Blue Shield® of Arizona, an Independent Licensee of the Blue Cross Blue Shield Association. Being in network with this highly …